| # | Drug | Count |
|---|---|---|
| 0 | 0XYGEN | 2 |
| 1 | ACETAMINOPHEN | 2 |
| 2 | ASPIRIN | 2 |
| 3 | ASPIRIN 325 MG | 2 |
| 4 | ASPIRIN 81 MG | 2 |
| 5 | AZACITIDINE | 2 |
| 6 | DARATUMUMAB | 2 |
| 7 | FLUTICASONE PROPIONATE | 2 |
| 8 | ISAVUCONAZONIUM SULFATE | 2 |
| 9 | LENALIDOMIDE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NINTEDANIB ESYLATE | 1 | 0.0029 |
| 1 | ISAVUCONAZONIUM SULFATE | 2 | 0.0005 |
| 2 | LEVALBUTEROL HYDROCHLORIDE | 1 | 0.0003 |
| 3 | PRAZOSIN | 1 | 0.0002 |
| 4 | BENDAMUSTINE HYDROCHLORIDE | 1 | 0.0001 |
| 5 | GRANISETRON HYDROCHLORIDE | 1 | 0.0001 |
| 6 | GRANISETRON | 1 | 0.0001 |
| 7 | TIOTROPIUM BROMIDE INHALATION SPRAY | 1 | 0.0001 |
| 8 | SIROLIMUS | 1 | 0.0001 |
| 9 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 2 | 0.0003 |
| 1 | Non-narcotic Antitussive [EPC] | 1 | 0.0001 |
| 2 | BCL-2 Inhibitor [EPC] | 2 | 0.0000 |
| 3 | Central alpha-2 Adrenergic Agonist [EPC] | 1 | 0.0000 |
| 4 | Complement Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Tetracycline-class Drug [EPC] | 1 | 0.0000 |
| 6 | Expectorant [EPC] | 2 | 0.0000 |
| 7 | Proteasome Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Histamine-2 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 9 | Serotonin-3 Receptor Antagonist [EPC] | 1 | 0.0000 |